NextCure Inc expected to post a loss of 67  cents a share - Earnings Preview

NextCure

01/03/2022 03:01

* NextCure Inc  NXTC.OQ   NXTC.O  is expected to show no
change in
quarterly revenue when it reports  results on March 2
(estimated). 
    * ​Refinitiv's mean analyst estimate for NextCure Inc is for
a
loss of 67 cents per share. For the same quarter last year, the
company reported a loss of 54 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for NextCure
Inc is
$17​, about 71.2% above​ its last closing price of $4.90. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.66       -0.67      -0.65     Beat    2.5
 Jun. 30 2021  -0.62       -0.61      -0.65     Missed  -6.4
 Mar. 31 2021  -0.61       -0.59      -0.60     Missed  -2.1​
 Dec. 31 2020  -0.61       -0.60      -0.54     Beat    9.7
 ​​Sep.        -0.56       -0.57      -0.59     Missed  -4.2
 30 2020                                                
 Jun. 30 2020  -0.51       -0.50      -0.53     Missed  -5.8​
 Mar. 31 2020  -0.44       -0.44      0.33      Beat    174.5
 Dec. 31 2019  -0.46       -0.45      -0.34     Beat    25.4
 This summary was machine generated March 1 at 03:01 GMT.  All
figures in US dollars  unless otherwise stated